Search

Author/Creator Eatock, Martin

1. Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma. (January 2020)

Authors:
Thomas, Anne; Virdee, Pradeep S.; Eatock, Martin; Lord, Simon R.; Falk, Stephen; Anthoney, D. Alan; Turkington, Richard C.; Goff, Matthew; Elhussein, Leena; Collins, Linda; Love, Sharon; Moschandreas, Joanna; Middleton, Mark R.
Journal:
European journal of cancer
Issue:
Volume 124(2020)
Page Start:
131
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P-OGC08 Translational Insights from the Dual ErbB Inhibition in Oesophago-gastric Cancer (DEBIOC) Clinical Trial - A Bioinformatic Analysis. (16th December 2021)

Authors:
Scanlon, Enya; Lavery, Anita; Stevenson, Leanne; Kennedy, Chloe; Byrne, Ryan; Walker, Andrew; Eatock, Martin; Middleton, Mark; Thomas, Anne; Turkington, Richard
Journal:
British journal of surgery
Issue:
Volume 108:Supplement 9(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗